OUR PRODUCTS

MOBILE APPS

GENERAL INFO

MRUS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Merus (MRUS) Earnings Date & Reports

Merus NV is a clinical-stage immuno-oncology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MRUS is expected to report earnings to fall 40.81% to -132 cents per share on October 30

Q3'25

Est.

$-1.32

Q2'25

Missed

by $1.07

Q1'25

Missed

by $0.29

Q4'24

Beat

by $0.48

Q3'24

Missed

by $0.60

The last earnings report on August 05 showed earnings per share of -223 cents, missing the estimate of -115 cents. With 85.08K shares outstanding, the current market capitalization sits at 4.84B.

View a ticker or compare two or three

Compare

MRUS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MRUS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MRUS showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Uppsalalaan 17

Phone

+31 302538800

Employees

229

Web

https://www.merus.nl